` 214450 (PharmaResearch Co Ltd) vs KOSPI 200 Comparison - Alpha Spread

P
214450
vs
K
KOSPI 200

Over the past 12 months, PharmaResearch Co Ltd has underperformed KOSPI 200, delivering a return of -44% compared to KOSPI 200's +106% growth.

Stocks Performance
214450 vs KOSPI 200

Loading...
214450
KOSPI 200
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
214450 vs KOSPI 200

Loading...
214450
KOSPI 200
Difference
www.alphaspread.com

Performance By Year
214450 vs KOSPI 200

Loading...
214450
KOSPI 200
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
PharmaResearch Co Ltd vs Peers

KOSPI 200
214450
ABBV
AMGN
GILD
VRTX
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

PharmaResearch Co Ltd
Glance View

Market Cap
3.1T KRW
Industry
Biotechnology

PharmaResearch Co Ltd is a South Korean life-science company best known for products built around regenerative medicine and medical aesthetics. It develops and sells prescription-style skin treatments, cosmetic products, and related health and beauty items, with a strong focus on collagen and DNA-based ingredients used in dermatology and anti-aging care. Its main customers are clinics, hospitals, distributors, and consumers that buy through pharmacies, medical channels, and retail or online channels. The company makes money by selling finished products and, in some cases, the underlying ingredients or branded treatments that other businesses use in their own offerings. What makes PharmaResearch different is that it sits between biotech and beauty. It takes pharmaceutical-style research and turns it into products that are sold both as medical treatments and as consumer-facing beauty items, giving it a role in a niche market where clinical credibility and brand appeal both matter.

Intrinsic Value
₩382 413.36
Undervaluation 21%
Intrinsic Value
Price ₩302 500
P
Back to Top